Special Issue "Untold Stories about Personalized Medicine: If You Thought Personalized Medicine Is for Others to Worry about, Think Again"

Quicklinks

A special issue of Journal of Personalized Medicine (ISSN 2075-4426).

Deadline for manuscript submissions: closed (31 August 2012)

Special Issue Editor

Guest Editor
Dr. Felix W. Frueh
Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill, USA
E-Mail: felix@frueh.us
Phone: +1 240 839 8374
Interests: biomarkers; clinical trials; clinical practice; translational research; diagnostics; comparative effectiveness

Special Issue Information

Dear Colleagues,

Technologies advances, new scientific insights, and improved routes of access are propelling personalized medicine into the clinic.  Patients are being treated more precisely with medicines that allow an a priori evaluation whether it may work, at what level of risk a patient may get exposed to them, which dose might be the most appropriate - in other words, these new medical products are developed with the idea in mind that the evidence of benefit must be demonstrated at the level of an individual patient, and in a predictable manner.  However, the opportunities this field of medicine offers are further reaching than simply treating (an individual) patient: a great deal of ethical and societal, regulatory and reimbursement, business and even political aspects are debated and will, for good or bad, impact the future of personalized medicine.  What are these factors exactly and how do or might they influence personalized medicine?  Why does personalized medicine not stop at the patient - doctor interaction, but may affect us in many more ways?  Does the ongoing debate over health care reform impact personalized medicine and if so how?  This special issue of the Journal of Personalized Medicine looks into the future and asks several stakeholders, some obvious and some less obvious how they view personalized medicine influencing, or being influenced by, their area of interest.

Dr. Felix W. Frueh
Guest Editor

Keywords

  • personalized medicine
  • translation
  • clinical application
  • stakeholders
  • ethics
  • society
  • business
  • politics
  • regulation
  • reimbursement
  • health care
  • reform
  • evidence
  • future

Published Papers (11 papers)

by , , ,  and
J. Pers. Med. 2013, 3(4), 288-305; doi:10.3390/jpm3040288
Received: 8 October 2013; in revised form: 18 October 2013 / Accepted: 18 October 2013 / Published: 25 October 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (388 KB) | HTML Full-text | XML Full-text

by  and
J. Pers. Med. 2013, 3(1), 1-13; doi:10.3390/jpm3010001
Received: 22 November 2012; in revised form: 19 December 2012 / Accepted: 19 December 2012 / Published: 27 December 2012
Show/Hide Abstract | Cited by 2 | PDF Full-text (240 KB) | HTML Full-text | XML Full-text

by ,  and
J. Pers. Med. 2012, 2(4), 257-266; doi:10.3390/jpm2040257
Received: 1 October 2012; in revised form: 9 November 2012 / Accepted: 12 November 2012 / Published: 26 November 2012
Show/Hide Abstract | Cited by 1 | PDF Full-text (668 KB) | HTML Full-text | XML Full-text

by , , , , , ,  and
J. Pers. Med. 2012, 2(4), 241-256; doi:10.3390/jpm2040241
Received: 5 September 2012; in revised form: 13 November 2012 / Accepted: 15 November 2012 / Published: 20 November 2012
Show/Hide Abstract | Cited by 4 | PDF Full-text (738 KB) | HTML Full-text | XML Full-text | Supplementary Files

by ,  and
J. Pers. Med. 2012, 2(4), 232-240; doi:10.3390/jpm2040232
Received: 18 September 2012; in revised form: 30 October 2012 / Accepted: 1 November 2012 / Published: 13 November 2012
Show/Hide Abstract | Cited by 5 | PDF Full-text (98 KB) | HTML Full-text | XML Full-text

by  and
J. Pers. Med. 2012, 2(4), 201-216; doi:10.3390/jpm2040201
Received: 31 August 2012; in revised form: 16 October 2012 / Accepted: 17 October 2012 / Published: 30 October 2012
Show/Hide Abstract | Cited by 8 | PDF Full-text (447 KB) | HTML Full-text | XML Full-text

by ,  and
J. Pers. Med. 2012, 2(4), 192-200; doi:10.3390/jpm2040192
Received: 3 September 2012; in revised form: 22 October 2012 / Accepted: 25 October 2012 / Published: 30 October 2012
Show/Hide Abstract | PDF Full-text (328 KB) | HTML Full-text | XML Full-text

by  and
J. Pers. Med. 2012, 2(4), 175-191; doi:10.3390/jpm2040175
Received: 20 September 2012; Accepted: 17 October 2012 / Published: 29 October 2012
Show/Hide Abstract | Cited by 1 | PDF Full-text (248 KB) | HTML Full-text | XML Full-text

by , , , , , ,  and
J. Pers. Med. 2012, 2(4), 158-174; doi:10.3390/jpm2040158
Received: 28 August 2012; in revised form: 1 October 2012 / Accepted: 10 October 2012 / Published: 17 October 2012
Show/Hide Abstract | PDF Full-text (493 KB) | HTML Full-text | XML Full-text

by ,  and
J. Pers. Med. 2012, 2(4), 149-157; doi:10.3390/jpm2040149
Received: 24 August 2012; in revised form: 21 September 2012 / Accepted: 21 September 2012 / Published: 1 October 2012
Show/Hide Abstract | Cited by 1 | PDF Full-text (275 KB) | HTML Full-text | XML Full-text | Supplementary Files

by , , , ,  and
J. Pers. Med. 2012, 2(4), 138-148; doi:10.3390/jpm2040138
Received: 2 August 2012; in revised form: 9 September 2012 / Accepted: 13 September 2012 / Published: 27 September 2012
Show/Hide Abstract | Cited by 1 | PDF Full-text (431 KB) | HTML Full-text | XML Full-text

Last update: 26 February 2014

J. Pers. Med. EISSN 2075-4426 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert